Literature DB >> 31277832

Consistency Between Three Different Ways of Administering the Short Form 6 Dimension Version 2.

Thomas G Poder1, Vickie Fauteux2, Jie He2, John E Brazier3.   

Abstract

BACKGROUND: The Short Form 6 Dimension (SF-6D) is a multi-attribute utility instrument derived from the Short-Form 36 Health Survey Version 2 (SF-36v2) quality of life questionnaire and is used to calculate quality-adjusted life years (QALYs) on a scale 0 to 1. The SF-6Dv2 is a new version of the SF-6D.
OBJECTIVE: The aim of this study was to assess the consistency of respondents' answers to 3 different methods to administer this new version.
METHODS: SF-6Dv2 utility values were generated from the SF-36v2 using the following: (1) full questionnaire with 36 items (SF-6Dv2SF-36); (2) subset questionnaire with 10 items (SF-6Dv2ind-10); (3) SF-6Dv2 administered as an independent instrument (rephrased questionnaire with only 6 items [SF-6Dv2ind-6]). The order of the 3 instruments was randomly allocated between respondents.
RESULTS: A total of 782 respondents from Quebec, Canada, were interviewed, out of whom 697 fully completed the survey. Very few deviations in respondents' answers were observed between the 3 instruments, with mean weighted kappa of 0.79 (range 0.61-0.91) and mean global consistency index of 70% (range 54-83). Maximal difference in utility values generated was found between SF-6Dv2ind-10 and SF-6Dv2ind-6 (mean difference 0.016, P < .01), whereas minimal difference was found between SF-6Dv2SF-36 and SF-6Dv2ind-10 (0.002, P = .38). No ceiling effect was observed.
CONCLUSIONS: The SF-6Dv2 was designed to derive utilities from the SF-36v2, and our results indicate that it is still preferable to use the full questionnaire, although the difference with other variants of the questionnaire is very small. To use the SF-6Dv2 as an independent instrument will thus introduce minimal bias in utility values generated.
Copyright © 2019 ISPOR–The Professional Society for Health Economics and Outcomes Research. Published by Elsevier Inc. All rights reserved.

Keywords:  SF-6Dv2; consistency

Year:  2019        PMID: 31277832     DOI: 10.1016/j.jval.2018.12.012

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  14 in total

1.  Mapping the cancer-specific FACT-B onto the generic SF-6Dv2.

Authors:  Azin Nahvijou; Hossein Safari; Mahmood Yousefi; Marziyeh Rajabi; Morteza Arab-Zozani; Hosein Ameri
Journal:  Breast Cancer       Date:  2020-07-25       Impact factor: 4.239

2.  A vision 'bolt-on' increases the responsiveness of EQ-5D: preliminary evidence from a study of cataract surgery.

Authors:  Mihir Gandhi; Marcus Ang; Kelvin Teo; Chee Wai Wong; Yvonne Chung-Hsi Wei; Rachel Lee-Yin Tan; Mathieu F Janssen; Nan Luo
Journal:  Eur J Health Econ       Date:  2020-01-04

3.  Population Norms for SF-6Dv2 and EQ-5D-5L in China.

Authors:  Shitong Xie; Jing Wu; Feng Xie
Journal:  Appl Health Econ Health Policy       Date:  2022-02-08       Impact factor: 3.686

4.  Development of the SF-6Dv2 health utility survey: comprehensibility and patient preference.

Authors:  Lynne Broderick; Jakob B Bjorner; Miranda Lauher-Charest; Michelle K White; Mark Kosinski; Brendan Mulhern; John Brazier
Journal:  J Patient Rep Outcomes       Date:  2022-05-12

5.  Analysis of SF-6D Health State Utility Scores: Is Beta Regression Appropriate?

Authors:  Samer A Kharroubi
Journal:  Healthcare (Basel)       Date:  2020-12-01

6.  Valuation of SF-6Dv2 Health States in China Using Time Trade-off and Discrete-Choice Experiment with a Duration Dimension.

Authors:  Jing Wu; Shitong Xie; Xiaoning He; Gang Chen; Gengliang Bai; Da Feng; Ming Hu; Jie Jiang; Xiaohui Wang; Hongyan Wu; Qunhong Wu; John E Brazier
Journal:  Pharmacoeconomics       Date:  2021-02-18       Impact factor: 4.981

7.  Validity of EQ-5D-5L health-related quality of life questionnaire in self-reported diabetes: evidence from a general population survey.

Authors:  Agnieszka Jankowska; Katarzyna Młyńczak; Dominik Golicki
Journal:  Health Qual Life Outcomes       Date:  2021-05-05       Impact factor: 3.186

8.  Self-Reported Satisfaction to Treatment, Quality of Life and General Health of Type 2 Diabetes Patients with Inadequate Glycemic Control from North-Eastern Romania.

Authors:  Elena-Daniela Grigorescu; Cristina-Mihaela Lăcătușu; Ioana Crețu; Mariana Floria; Alina Onofriescu; Alexandr Ceasovschih; Bogdan-Mircea Mihai; Laurențiu Șorodoc
Journal:  Int J Environ Res Public Health       Date:  2021-03-21       Impact factor: 3.390

9.  Assessment of the Quality of Life in Patients before and after Coronary Artery Bypass Grafting (CABG): A Prospective Study.

Authors:  Stana Pačarić; Tajana Turk; Ivan Erić; Želimir Orkić; Anamarija Petek Erić; Andrea Milostić-Srb; Nikolina Farčić; Ivana Barać; Ana Nemčić
Journal:  Int J Environ Res Public Health       Date:  2020-02-22       Impact factor: 3.390

10.  EQ-5D-5L and SF-6Dv2 utility scores in people living with chronic low back pain: a survey from Quebec.

Authors:  Thomas G Poder; Liang Wang; Nathalie Carrier
Journal:  BMJ Open       Date:  2020-09-15       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.